Back to Dashboard
S-2121Senate2025-06-18Health

SUPPORT for Patients and Communities Reauthorization Act of 2025

YourVoice.Now Summary

Your MoneyWorkers & JobsCivil LibertiesCorporate BenefitsTransparency & Accountability

Renews two dozen federal addiction programs through 2030, most with more money for overdose rescue, treatment, and recovery.

Your Money

Fentanyl and xylazine test strips — grants may now fund them

State and Tribal grants could pay for strips that detect fentanyl or xylazine in a drug. This applies only where state and federal law already allow the strips.

Overdose rescue training for first responders — $57 million a year

Grants train police, fire, and EMS crews to give overdose reversal drugs. The yearly limit rises from $36 million, and the training now covers overdoses from any drug, not just opioids.

988 suicide line — must fix known computer security holes

The 988 crisis line would have to close known security weak spots and report break-ins to federal officials. A government watchdog would also study the line's risks within 180 days.

Live-in treatment for pregnant women — $38.9 million a year

These grants pay for live-in addiction treatment where women can keep their children with them. The yearly limit rises from $29.9 million and runs through 2030.

Groups run by people in recovery — $5 million to $17 million

Groups run by people in recovery would see their yearly limit more than triple. They offer peer support, help finding recovery housing, and job connections.

Care for children after trauma — about $99 million a year

A national network treats children after abuse, violence, or disaster. The limit is $98.9 million for 2026 through 2028, then $100 million for 2029 and 2030.

Long-acting addiction shots — pharmacies may ship them to doctors

Pharmacies could send more addiction medicines straight to a doctor's office for the doctor to give. This covers drugs that must be watched after they are given, such as monthly shots or implants.

Workers & Jobs

Loan payoff for addiction treatment staff — $40 million a year

The government helps pay off school loans for people who work in addiction treatment where help is scarce. The yearly limit rises from $25 million.

Job help for people in recovery — $5 million to $12 million

These grants pay for job training and placement for people recovering from addiction. They go to areas with the highest overdose deaths and joblessness.

Rides to work or treatment — up to 5% of job grants

Grantees could spend up to 5 percent of the money on rides. The ride must go to a job, to job training, or to addiction treatment.

More groups may train drug prescribers — counts back to 2022

Doctors, dentists, and nurses must take eight hours of addiction training to prescribe controlled drugs. Nine more professional groups could provide that training, treated as if approved in December 2022.

Civil Liberties

Sewage testing for drug use — allowed under overdose grants

States could use overdose grant money to test wastewater for drug patterns in a community. The bill says this must follow federal and state privacy laws.

Corporate Benefits

One-company control of state prescription databases — HHS may not require it

Every state runs a database that tracks controlled-drug prescriptions. Federal officials could not force a state to buy from one company. They can only require open, shared standards.

Opioid makers' approvals — FDA to weigh label changes and withdrawals

The FDA must set a timeline for reviewing approved opioid painkillers. It would decide whether they need new warnings, more safety studies, or removal from the market.

Transparency & Accountability

FDA plan on opioid painkillers — posted online within one year

The FDA must publish a plan on its website for re-examining approved opioid painkillers. It must also report what it is doing to support non-addictive pain treatments.

Public comment on opioid drug rules — FDA must invite it

Anyone could send the FDA evidence about how opioid painkillers are used and how safe they are. The FDA must take that input as it builds its plan.

New work group on fentanyl-laced drugs — yearly reports to Congress

Federal agencies would form a group on overdoses from drugs cut with fentanyl, and report to Congress each year. It must consult families who lost someone. The committee it sits under would run through September 30, 2030.

Recovery job grants — must report who found work and their pay

Groups getting recovery job grants would have to report how many people found and kept work, and what they earned. A final report is due September 30, 2030.

More about this bill

Federal money for addiction treatment, overdose rescue, and recovery support would grow for five years. The 2018 law behind these programs set spending limits only through 2023. New limits would run from 2026 through 2030, and most are higher. If addiction has touched your family, this is the money behind the help near you. Grants to states and tribes for overdose prevention would rise to $505.6 million a year. Training first responders to reverse overdoses would grow from $36 million to $57 million. Live-in treatment for pregnant women would go from $29.9 million to $38.9 million. Groups run by people in recovery would jump from $5 million to $17 million. Care for children after trauma would get about $99 million a year. Many programs would widen from opioids to every drug that causes overdose. State grants could buy fentanyl and xylazine test strips. Job grants for people in recovery could pay for rides to work or treatment. The 988 suicide line would have to fix known computer security holes. These are spending limits, not checks. Congress would still have to vote the money each year, and your own costs would not change.

Congressional Summary

SUPPORT for Patients and Communities Reauthorization Act of 2025 This bill reauthorizes and revises Department of Health and Human Services (HHS) programs that address substance use disorders, overdoses, and mental health. For example, the bill reauthorizes for FY2026-FY2030 grant and other programs relating to • addressing substance use disorders with respect to pregnant and postpartum women, • prevention and recovery from substance use disorders for youth, • housing for individuals in recovery from substance use disorders, • community organizations facilitating recovery from substance use disorders, • loan repayment for certain health care providers treating substance use disorders, • prevention of overdoses of controlled substances, • treatment of children experiencing psychological trauma, and • mental and behavioral health education and training for medical and allied health students. Also, the bill revises several programs, including by (1) expanding a program that supports resources for first responders to include the purchase of drugs or devices to treat non-opioid overdoses, (2) expanding a program that supports employment services for individuals in recovery so as to allow for the provision of related transportation services, and (3) temporarily authorizing a regional technical assistance center to assist the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support. Additionally, the bill establishes new requirements for HHS, including requirements relating to • protecting the National Suicide Prevention Lifeline program from cybersecurity threats, • establishing a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and • reviewing and potentially revising the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act.

Details

Congress
119th
Chamber
Senate
Status
summarized
Action
Introduced in Senate
Action Date
2025-06-18
Date Added
2026-06-24
Source
Congress.gov →

Like reading a bill in plain English?

We're building an app that does this for every bill in Congress and lets you tell your reps how you want them to vote. We're a small team getting ready to launch, and we're trying to show investors that real people want this. Be one of them. Help us get it built. Leave your email and we'll tell you the moment the app is ready.

By default, we'll only email you once — when the app launches. Unless you opt in below, you won't receive anything else. We don't share or sell your email.